Johnson Pharmacare has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of Board of Directors of the Company will be held on Thursday 14th October 2021, to approve Sub-Division of Face Value of Equity Shares of Rs 10 into Rs 1 per Equity Share; to change the Clause V - Authorised Capital of Memorandum of Articles according; to approve notice of General Meeting to seek approval for the above mentioned items as recommended by Board; and any other business as Board deem fit to discuss, with the permission of the Chairman.
The above information is a part of company’s filings submitted to BSE.
